MachineU > China Products > Chemicals
Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical
Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical
Specifications
Brand Name :
Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical
Model Number :
cTnl/MYO/CK-MB
Certification :
CE
Place of Origin :
Henan
MOQ :
To be negotiated
Price :
To be negotiated
Supply Ability :
10000 Kit/Kit per Day
Delivery Time :
To be negotiated
Packaging Details :
Kit
Sample type :
Whole Blood,Serum,Plasma
Mixing requirements :
Mix well
Sample size after dilution :
60μL
Reaction time :
15min
Detection range :
cTnl:0.1~50ng/mL;MYO:10~200ng/mL;CK-MB:0.8~100ng/mL
Application Department :
Outpatient, emergency
Description

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

CTnI/MYO/CK-MB Overview

The isoenzyme troponin I/myoglobin/creatine kinase (cTnI/Myo/CK-MB) includes the following three indicators: The combined detection of troponin I (cTnI), myoglobin (Myo) and creatine kinase isoenzyme (CK-MB) is of great importance for the Early diagnosis of acute myocardial diseases such as AMI

American Society for Clinical Biochemistry ( NACB ) Practice Guide

Signs of myocardial necrosis should be detected in all patients with ACS
Troponin is a key marker in the diagnosis of myocardial infarction
Myoglobin binding specific markers of myocardial necrosis (eg, cTnI/CK-MB) may help clear or diagnose myocardial infarction more quickly.

MYO CK-MB cTnI
molecular weight 17.8KD 86KD 22.5KD
Rise time 1-2h 4-6h 3-6h
Peak time 6-9h 24h 12-16h
recovery time 18-30h 2-3d 4-10d
Clinical value

1. The most important AMI map was released in the first stage
2. Re-diagnose America and the best indication to evaluate the effect of re-treatment

1. Font size or re-launch
2. The most valuable mark of the highest non-ST part of MI

1. Preferential signs for diagnosing AMI
2. Judge the size of the gap and the risk strategy

cTnI/MYO/CK-MB Performance Index

Detection range sample size Sample type Test time
cTnI MYO CK-MB 60μl Whole blood / serum / plasma 15min
0.1~50ng/mL 10~200ng/mL 0.8~100ng/mL

CTnI/MYO/CK-MB Clinical Significance

  • This is for the initial and strategic diagnosis of corneal syndrome risk
  • Defining the area of myocardial infarction
  • Different diagnosis of different causes of chest pain
  • Beware of myocardial injury for a variety of reasons
  • Evaluation of clinical evidence of some medical drugs

Possibility of outcome
cTnI CK-MB MYO Clinical possibility

+

 + + Myocardial infarction / myocardial injury can basically be diagnosed and the time of onset is 12-24 hours.
+ + - It can basically be diagnosed as a myocardial infarction injury / myocardial infarction injury, and the detection time is more than one day that has passed during the myocardial identification window.
+ - - Myocardial damage occurs for a few days and should be rechecked in a few hours.
+ - + In patients with hepatic myocardial injury, symptoms may last for more than three days, and in patients with re-injury or necrotic areas due to blood clots.
- + + In early myocardial ischemia, liver myocardial injury following monitoring of CTNI in 4-8 hours is recommended.

-

 - + It is recommended to check CTNN in 4-8 hours.
The reserves can be caused by other diseases such as creative work, musculoskeletal injuries, and liver and kidney disease.
- + - For minor myocardial injury, we recommend CT monitoring in 4-8 hours.
It may not be myocardial injury and the test time was through my window.

-

 - - The possibility of ischemic myocardial injury is generally ruled out. When in doubt, it is recommended to check every two to four hours.

Application Department

Emergency outpatient departments, Cardiovascular Examination Centers, ICUs and Chest Pain Centers

CTnI/MYO/CK-MB Clinical Comparison

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Company profile

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency ClinicalCombined CTnI Myo CK-MB Rapid Test For Outpatient Emergency ClinicalCombined CTnI Myo CK-MB Rapid Test For Outpatient Emergency ClinicalCombined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Product tags

ecg biocare ie3

,

cardiac troponin i test

,

immunoassay analyser
Send your message to this supplier
Send Now

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Ask Latest Price
Product Detail
Brand Name :
Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical
Model Number :
cTnl/MYO/CK-MB
Certification :
CE
Place of Origin :
Henan
MOQ :
To be negotiated
Price :
To be negotiated
Contact Supplier
Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Henan Lantian Medical Supplies Co.,Ltd.

Active Member
4 Years
henan, zhengzhou
Since 2016
Business Type :
Manufacturer, Exporter, Seller
Main Products :
Ag Rapid Test Kit, COVID-19 Test Kit, Coronavirus Neutralizing Antibody Rapid Test
Employee Number :
500~1000
Certification Level :
Active Member
Discover similar products
View More

Find Similar Products By Category:

Supplier Homepage Products Ag Rapid Test Kit
MachineU China Products Chemicals
Contact Supplier
Submit Requirement